# LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
> **ANDA208336** · Abbreviated New Drug Application (Generic) · Sponsor: SUNSHINE · Approved 2021-08-30
## Drug
- **FDA Application Number:** ANDA208336
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** Linagliptin
- **Active ingredients:** LINAGLIPTIN; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SUNSHINE
- **First approval:** 2021-08-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208336)
---
*MORVS · CC0 1.0*